- Obsessive-compulsive disorder:
- Initially 50mg nocte
- May increase by 50mg/day every 4-7 days
- Maintenance: 100-300mg daily
- Max: 300mg/day
- Doses over 150mg daily given in divided doses
- If no improvement after 10 weeks, reconsider treatment
- Social anxiety disorder (Off-label):
- Initially 50mg nocte
- May increase by 50mg at 1 week interval
- Maintenance: 100-300mg daily
Tablet: 100mg
Taken without regards to meals
Selective serotonin reuptake inhibitor (SSRI)
- Nausea
- Headache
- Insomnia
- Somnolence
- Asthenia
- Diarrhea
- Dizziness
- Anorexia
- Nervousness
- Xerostomia
- Ejaculatory dysfunction
- Dyspepsia
- Decreased libido
- Constipation
- Flu syndrome
- Anxiety
- Tremor
- Diaphoresis
- Vomiting
- Abdominal pain
- Yawning
- Anorgasmia
- Ecchymosis
- Palpitations
- Abnormal dreams
- Agitation
- Paresthesia
- Visual disturbance
- Elevated LFTs
- Hypersensitivity to components/class
- MAO inhibitor use within 14 days
WARNING:
- Increased suicidality risk in children, adolescents and young adults (<24 years) with major depressive or other psychiatric disorders
- Alosetron
- Cisapride
- Isocarboxazid
- Linezolid
- Mavacamten
- Methylene blue injection
- Phenelzine
- Pimozide
- Ramelteon
- Selegiline
- Thioridazine
- Tizanidine
- Tranylcypromine
Drug Status
| Availability | Prescription only |
| Pregnancy | Category C |
| Breastfeeding | Use with caution |
| Schedule | Controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Faverin | 100mg | Tablet | 30’s | Abbott Labs | Harley’s Ltd |